{"id":815272,"date":"2025-02-20T01:03:07","date_gmt":"2025-02-20T06:03:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/"},"modified":"2025-02-20T01:03:07","modified_gmt":"2025-02-20T06:03:07","slug":"argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/","title":{"rendered":"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>February 20, 2025<\/strong><\/p>\n<p>        <strong>Amsterdam, the Netherlands<\/strong> \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update.<\/p>\n<p align=\"justify\">A webcast of the live call may be accessed on the Investors section of the argenx website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F4HmPSeBNPEIFrBpYxN456jZYzLI9zDqfTYfWRSVH755u8SLnw01482JFGCIikxV3kCo1_XDTYNxU7isbPNMWX5lTKMlDq1qZQLPlm95sSI=\" rel=\"nofollow\" target=\"_blank\">argenx.com\/investors<\/a>. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.<\/p>\n<p align=\"justify\">Dial-in numbers:<\/p>\n<p align=\"justify\">Belgium\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 32 800 50 201<br \/>France\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 33 800 943355<br \/>Netherlands\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 31 20 795 1090<br \/>United Kingdom 44 800 358 0970<br \/>United States\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1 800 715 9871<br \/>Japan\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 81 3 4578 9081<br \/>Switzerland\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 41 43 210 11 32<\/p>\n<p align=\"justify\">Use the access code 3810049 to join the call. Please dial in 15 minutes prior to the live call.<\/p>\n<p align=\"justify\">\n        <strong>About argenx<\/strong>\n      <\/p>\n<p align=\"justify\">argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker, globally in the U.S., Japan, Israel, the EU, the UK, China and Canada. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WVFc4wlNikzgCOhH2B3xBjbYArTov1i1cCwBN0j_2ueo8oo9z_u1RUGHQI3UpmT2lXQDuDhmUd7h6sruGS6h9g==\" rel=\"nofollow\" target=\"_blank\">www.argenx.com<\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v-tPpBf2U8uw3Pjuk-7evGS2jl_U8qj6EKAnjLGfceUzt-nji58kiRbiV4YSgdDFTXOQpTGRyXChLF6yE-wi_7Hpv5DHXBpRP-xsMDPPpK06eLaquCy8EemvjUKQ0o-5b8CxFNXG6w-UG19OO6zRRQJicIQT7H4_jnlgfksuz6nW8pn7G8XPEDy5gf_WsoWFfbjHiOaTZxvjO_viF_YY0j67Q7gNCgqxspj_gn-dnDeu35-Rrc2B_GkxBi3T1DJFgjj9BAwYUc_lFRnVKqokhg7lkXXf685SfIOxciceyrznMV_-p8219gLnvAEgkhcy9H6nom3sNOrBTbB-luS_l31QxjQouD7btGUEIcoE18sKeIDivEIh313aojVtCpgk2MbWM3Q_OhjU57pCfvFNnAY74AMvz7TgRthI7kQKYVU8Ga-0X43Nyocg_i7MK3K1_5nBaNxHDvnzBgQ3C_AjqrCWR53NkCrGOIaYfFgoi5PSodOq_wPaBc3dL3-jZg3HqnyN-p-oxjm3oiKps5XR0QEVFRLuh4Xp_S8iHHKA6tAEGvn0SDUgjgnsVDBzunNLGnHrgjyJ18SQ8sdnpy67Gg==\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FEBnfIadQBF5uJM8EoREMLujXqKWwph39CnecqwiqOQrDqTBp-s4NN6YeuNhWBVaK7NiPVmsnIkIhNhKbRn_gEUKzoIBhvlkXDxVb2ha9824F9XSzm6lIFzePUe0f36cqL4ozWJLC2YLxQTIw4WQarDp95MaPCD8KDRa3KTzmZL0FqL6G3QIC4qstEI_hiGnsStjuGDspCN7clMqQ5c0uzSzI6Zfmzq25dSOtxGzKL5t7BxpVWrOVqR9nIa_TQgDmRVl2HWVIhHZua4BqBEBiJvooHXJJXcaOZLJqCKpNaes87SJYVE7Hf-oGZ3SuasfpHg23aCw7oNieaWzXtHEMiRmG6AyTLpF7y08gR9e7E1Dm4TjY_Ql4Bm2z42n6MNaHXShzJv0J3vK2bKFRBb-91neZfUIc2_Buue_frBEi4b43niaHAP6eFODgDBDHB1t233OW7TGKags6ejN-Niz2zP3N4WSBVZd7QSIQkXD-rPuOUPL3WfV1iPPtcXJlv72xrdTbA7RhFBtU1QdBadwNFzipwjfrU01usWw1egLHye7ffJT-7_bHoSZ25_XvIZy\" rel=\"nofollow\" target=\"_blank\">X<\/a> (formerly known as Twitter), and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uCxmCfQ_3gocl7apqtRIjJqQ9sNtvm90nIk7C5cjmDoMO49Lf8Wdp7Zdwgftlt12Zi6aplMDixspCb8PeziqUs-ymJ9sPGZxLmJxHKsS_MToi13t53Ymj59lEgDnA2JJv2E8qZXmUgJgTQouDhDrMtnNAwrmSroawTCKdefmcHq2302Lh0pTswS8yyXUFWDTY01Xu42vM_4kWIAC7MWWbZvczRac3b4H3llO0qghfwhe_VFfABStIFrV75IYTv4w9DyOcRHT4STGhFWjED04Q1bkgo8TaMklYGhRpdtRiUx8Y9GPU7m6FnAVnOcQVjIJEBt3-oqpBpY0rIALUsZZf69m6mtHBLbWUcYZU2yUEwfT9YpoNPCGJyVj06MGOEynVa4CtnpVLvXRpNAbOll75PmizLoCLDbY7LAsnvjOb6ED-IP2VJQ4Q3Q36ioBgx1i4uDe-TzZpYjuubZUXDJBsw1UKN5I_ZI1LPZcS4NSqig1CWXCCUpjKdWNl4QQZo20HonPREll-cA5rg8mPhnTN00jVWoVC0TXELrQvHW8TdiktQiLnN7ZNOD3G3hqGjOhnfPztqFBrSVlRcuo4YXjxw==\" rel=\"nofollow\" target=\"_blank\">Instagram<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Media:<\/strong>\n      <\/p>\n<p align=\"justify\">Ben Petok<br \/>bpetok@argenx.com<\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong>\n      <\/p>\n<p align=\"justify\">Alexandra Roy (US)<br \/>aroy@argenx.com<\/p>\n<p align=\"justify\">Lynn Elton (EU)<br \/>lelton@argenx.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MjQ4ZTczYWQtMmI1MC00ZmRlLTkxODgtOWJhNGJmNmU2OGRkLTEwMTUzNDU=\/tiny\/argenx-SE.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>February 20, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Dial-in numbers: Belgium\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 32 800 50 201France\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 33 800 943355Netherlands\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 31 20 795 1090United &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815272","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"February 20, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Dial-in numbers: Belgium\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 32 800 50 201France\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 33 800 943355Netherlands\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 31 20 795 1090United &hellip; Continue reading &quot;argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T06:03:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025\",\"datePublished\":\"2025-02-20T06:03:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/\",\"name\":\"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==\",\"datePublished\":\"2025-02-20T06:03:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/","og_locale":"en_US","og_type":"article","og_title":"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - Market Newsdesk","og_description":"February 20, 2025 Amsterdam, the Netherlands \u2013 argenx (Euronext &amp; Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, February 27, 2025 at 2:30 PM CET (8:30 AM ET) to discuss its full year 2024 financial results and provide a fourth quarter business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com\/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Dial-in numbers: Belgium\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 32 800 50 201France\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 33 800 943355Netherlands\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 31 20 795 1090United &hellip; Continue reading \"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T06:03:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025","datePublished":"2025-02-20T06:03:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/","name":"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==","datePublished":"2025-02-20T06:03:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA0OTQ1NyM0MDIwNjMzMjgjMjAwMzc3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/argenx-to-report-full-year-2024-financial-results-and-fourth-quarter-business-update-on-february-27-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815272"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815272\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815272"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}